FDA Never Saw Birth-Defect Tests On GSK Drug, Families Say
Families suing GlaxoSmithKline who claim the anti-nausea medication Zofran led to birth defects argued Thursday in Massachusetts federal court that crucial tests were not shown to the U.S. Food and Drug...To view the full article, register now.
Already a subscriber? Click here to view full article